David R. Raleigh, MD, PhD

About David R. Raleigh, MD, PhD

David R. Raleigh, MD, PhD, With an exceptional h-index of 40 and a recent h-index of 39 (since 2020), a distinguished researcher at University of California, San Francisco, specializes in the field of Cancer predisposition, Hedgehog signaling, Neurofibromatosis, Brain tumors, Development.

His recent articles reflect a diverse array of research interests and contributions to the field:

Leveraging Single-Cell Sequencing to Classify and Characterize Tumor Subgroups in Bulk RNA-Sequencing Data

Canine meningiomas are comprised of 3 DNA methylation groups that resemble the molecular characteristics of human meningiomas

Radiotherapy dose escalation for high-risk meningiomas after subtotal resection

Multiomic screening of invasive GBM cells reveals targetable transsulfuration pathway alterations

NAB2::STAT6 fusions and genome‐wide DNA methylation profiling: Predictors of patient outcomes in meningeal solitary fibrous tumors

Meningioma transcriptomic landscape demonstrates novel subtypes with regional associated biology and patient outcome.

“De novo replication repair deficient glioblastoma, IDH-wildtype” is a distinct glioblastoma subtype in adults that may benefit from immune checkpoint blockade

Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance

David R. Raleigh, MD, PhD Information

University

Position

___

Citations(all)

7248

Citations(since 2020)

5274

Cited By

3624

hIndex(all)

40

hIndex(since 2020)

39

i10Index(all)

90

i10Index(since 2020)

86

Email

University Profile Page

Google Scholar

David R. Raleigh, MD, PhD Skills & Research Interests

Cancer predisposition

Hedgehog signaling

Neurofibromatosis

Brain tumors

Development

Top articles of David R. Raleigh, MD, PhD

Title

Journal

Author(s)

Publication Date

Leveraging Single-Cell Sequencing to Classify and Characterize Tumor Subgroups in Bulk RNA-Sequencing Data

bioRxiv

Arya Shetty

Su Wang

A Basit Khan

Collin W English

Shervin Hosseingholi Nouri

...

2024

Canine meningiomas are comprised of 3 DNA methylation groups that resemble the molecular characteristics of human meningiomas

Acta Neuropathologica

Naomi Zakimi

Christina N Mazcko

Christine Toedebusch

Gregory Tawa

Kevin Woolard

...

2024/6

Radiotherapy dose escalation for high-risk meningiomas after subtotal resection

David R Raleigh

2024/4/1

Multiomic screening of invasive GBM cells reveals targetable transsulfuration pathway alterations

The Journal of Clinical Investigation

Joseph H Garcia

Erin A Akins

Saket Jain

Kayla J Wolf

Jason Zhang

...

2024/2/1

NAB2::STAT6 fusions and genome‐wide DNA methylation profiling: Predictors of patient outcomes in meningeal solitary fibrous tumors

Brain Pathology

Kathryn L Eschbacher

Quynh T Tran

Evgeny A Moskalev

Sarah Jenkins

Karen Fritchie

...

2024/3/24

Meningioma transcriptomic landscape demonstrates novel subtypes with regional associated biology and patient outcome.

bioRxiv

H Nayanga Thirimanne

Damian Almiron Bonnin

Nicholas Nuechterlein

Sonali Arora

Matt Jensen

...

2024

“De novo replication repair deficient glioblastoma, IDH-wildtype” is a distinct glioblastoma subtype in adults that may benefit from immune checkpoint blockade

Acta Neuropathologica

Sara Hadad

Rohit Gupta

Nancy Ann Oberheim Bush

Jennie W Taylor

Javier E Villanueva-Meyer

...

2024/6

Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance

Nature communications

Harish N Vasudevan

Emily Payne

Cyrille L Delley

S John Liu

Kanish Mirchia

...

2024/1/12

A Prospective Registry Study of 68Ga-DOTATATE PET/CT Incorporation Into Treatment Planning of Intracranial Meningiomas

International Journal of Radiation Oncology* Biology* Physics

Haley K Perlow

Ansel P Nalin

Demond Handley

Yevgeniya Gokun

Dukagjin M Blakaj

...

2024/3/15

Epigenetic reprogramming shapes the cellular landscape of schwannoma

Nature communications

S John Liu

Tim Casey-Clyde

Nam Woo Cho

Jason Swinderman

Melike Pekmezci

...

2024/1/12

Meningioma: International Consortium on Meningiomas (ICOM) consensus review on scientific advances & treatment paradigms for clinicians, researchers, and patients

Justin Z Wang

Alexander P Landry

David R Raleigh

Felix Sahm

Kyle M Walsh

...

2024/5/2

Adverse radiation effect versus tumor progression following stereotactic radiosurgery for brain metastases: Implications of radiologic uncertainty

Journal of Neuro-oncology

Mia Salans

Lisa Ni

Olivier Morin

Benjamin Ziemer

Dante PI Capaldi

...

2024/2/5

301 Even Heterozygous Loss of CDKN2A B Greatly Accelerates Recurrence in Aggressive Meningioma

Neurosurgery

A Basit Basit Khan

Collin English

William Chen

Prazwal Athukuri

James Bayley

...

2024/4/1

Pan-cancer copy number variant analysis identifies optimized size thresholds and co-occurrence models for individualized risk-stratification

David Raleigh

Minh Nguyen

William Chen

Naomi Zakimi

Kanish Mirchia

...

2024/1/11

Meningioma-Induced Hyperostosis Is Associated with TRAF7 Gain-of-Function Missense Mutation in Primary Patient-Derived Meningioma Cells

Journal of Neurological Surgery Part B: Skull Base

Charlotte D Eaton

Ezequiel Goldschmidt

Zhenhong Chen

Jacob S Young

David R Raleigh

2024/2

Eed controls craniofacial osteoblast differentiation and mesenchymal proliferation from the neural crest

bioRxiv

Tim Casey-Clyde

S John Liu

Juan Antonio Camara Serrano

Camilla Teng

Yoon-Gu Jang

...

2024

Targeted DNA Sequencing Reveals Molecular Factors Associated with Clinical Outcomes in Recurrent Glioblastoma

Neurosurgery

Nadeem Al-Adli

William Chen

Jacob Young

Kanish Mirchia

Zain Peeran

...

2024/4/1

Gene transcript fusions are associated with clinical outcomes and molecular groups of meningiomas

Acta Neuropathologica

Naomi Zakimi

Minh P Nguyen

David R Raleigh

2024/6

Mutational status and clinical outcomes following systemic therapy with or without focal radiation for resected melanoma brain metastases

World Neurosurgery

Harish N Vasudevan

Matthew S Susko

Lijun Ma

Jean L Nakamura

David R Raleigh

...

2023/2/1

886 Stereotactic Radiosurgery Reprograms Macrophage, Microglia, and T Cell Populations in the Glioblastoma Immune Microenvironment

Neurosurgery

Jacob Young

Nam Woo Cho

Calixto-Hope Lucas

Kyounghee Seo

Raquel Santos

...

2023/4/1

See List of Professors in David R. Raleigh, MD, PhD University(University of California, San Francisco)